T and NK cell based cellular therapies to improve the outcome of haploidentical stem cell transplantation for the treatment of high risk and refractory leukemias

Datum: 
Mittwoch, 20 Februar, 2013 - 16:30
Referent: 
L. Uharek, Charité SCF, Berlin